Sp Asset Management Abb Vie Inc. Transaction History

Sp Asset Management

$731 Million
Q3 2022

A detailed history of Sp Asset Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Sp Asset Management holds 186,903 shares of ABBV stock, worth $31.4 Million. This represents 3.43% of its overall portfolio holdings.

Number of Shares

186,903

Previous 173,590 7.67%

Holding current value

$31.4 Million

Previous $26.6 Million 5.65%

% of portfolio

3.43%

Previous 3.39%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $1.79 Million - $2.05 Million	13,313 Added 7.67%	186,903 $25.1 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $33,304 - $42,340	242 Added 0.14%	173,590 $26.6 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $236,772 - $293,767	1,794 Added 1.05%	173,348 $28.1 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $201,323 - $254,732	1,874 Added 1.1%	171,554 $23.5 Million
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $4.02 Million - $4.57 Million	37,825 Added 28.69%	169,680 $18.4 Million

Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $319,312 - $355,732	3,035 Added 2.36%	131,855 $15.6 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $950,367 - $1.05 Million	9,290 Added 7.77%	128,820 $14.8 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $105,924 - $143,009	1,316 Added 1.11%	119,530 $13 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $2.32 Million - $2.72 Million	27,011 Added 29.62%	118,214 $11.1 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $81,147 - $108,587	1,106 Added 1.23%	91,203 $8.95 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $306,181 - $464,209	4,747 Added 5.56%	90,097 $6.86 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $22,504 - $28,158	-312 Reduced 0.36%	85,350 $7.56 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $103,602 - $124,559	1,645 Added 1.96%	85,662 $6.49 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $91,980 - $117,572	1,400 Added 1.69%	84,017 $6.11 Million
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $66,340 - $78,079	-860 Reduced 1.03%	82,617 $6.66 Million
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $400,226 - $493,587	5,141 Added 6.56%	83,477 $7.7 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $20,004 - $22,239	-225 Reduced 0.29%	78,336 $7.4 Million
Q2 2018 Sep 07, 2018	BUY	$89.78 - $106.23 $7.05 Million - $8.35 Million	78,561 New	78,561 $7.4 Million

Others Institutions Holding ABBV

# of Institutions

3,654

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sp Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Sp Asset Management with notifications on news.

Account

Sp Asset Management Abb Vie Inc. Transaction History